KRAS and cancer: While these results are broadly in line with the previously reported role of activated KRAS in supporting de novo serine synthesis17, it is clear that other genetic alterations – such as amplification of PHGDH in MDA-MB-468 cells14 – also contribute to the dependence of cancer cells on a supply of exogenous serine.